Interactions between fatty acids and arginine metabolism: Implications for the design of immune-enhancing diets

Journal of Parenteral and Enteral Nutrition

Volumn 29, Issue SUPPL. 1, 2005, Pages

  Bansal, Vishal ^a   Syres, Kimberly M ^a   Makarenkova, Valeryia ^a   Brannon, Ryan ^a   Matta, Benjamin ^a   Harbrecht, Brian G ^a   Ochoa, Juan B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; ARGININE; INTERLEUKIN 13; N(G) HYDROXYARGININE; NITRIC OXIDE; OMEGA 3 FATTY ACID; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DIET; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID METABOLISM; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALIA;

EID: 12544258346     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/01486071050290s1s75     Document Type: Conference Paper

References (35)

1. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg. 1996;20:454-459.
2. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery. 1996;119:316-325.
3. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock. 1999;11:153-159.
4. Puyana J, Pellegrini J, De A, Kodys K, Silva W, Miller C. Both T-helper-1-and T-helper-2-type lymphokines are depressed in posttrauma anergy. J Trauma Injury Infect Crit Care. 1998;44:1037-1046.
5. Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg. 1999;134:428-433.
6. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di CV. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763-1770.
7. Heyland DK. Nutritional support in the critically ill patients: a critical review of the evidence. Crit Care Clin. 1998;14:423-440.
8. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992;112:56-67.
9. Reynolds JV, Daly JM, Zhang S, et al. Immunomodulatory mechanisms of arginine. Surgery. 1988;104:142-151.
10. Ochoa JB, Bernard AC, O'Brien WE, et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg. 2001;233:393-399.
11. Ochoa JB, Strange J, Kearney P, Gellin G, Endean E, Fitzpatrick E. Effects of L-arginine on the proliferation of T lymphocyte subpopulations. JPEN J Parenter Enteral Nutr. 2001;25:23-29.
12. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214:621-626.
13. Trebble TM, Wootton SA, Miles EA, et al. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr. 2003;78:376-382.
14. Endres S, Meydani SN, Ghorbani R, Schindler R, Dinarello CA. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol. 1993;54:599-603.
15. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320:265-271.
16. Corraliza IM, Soler G, Eichmann K, Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun. 1995;206:667-673.
17. Konarska L, Tomaszewski L. A simple quantitative micromethod or arginase assay in blood spots dried on filter paper. Clin Chim Acta. 1986;154:7-17.
18. Bradford MM. A rapid and sensitive method for binding. Anal Biochem. 1976;72:248-254.
19. Meydani SN. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function. Nutrition. 1996;12(Suppl):S8-S14.
20. Meydani SN. Modulation of cytokine production by dietary polyunsaturated fatty acids. Proc Soc Exp Biol Med. 1992;200:189-193.
21. Shaheen SO, Sterne JA, Thompson RL, Songhurst CE, Margetts BM, Burney PG. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med. 2001;164:1823-1828.
22. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361:477-485.
23. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495-505.
24. Ilowite NT, Copperman N, Leicht T, Kwong T, Jacobson MS. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol. 1995;22:1347-1351.
25. Blonk MC, Bilo HJ, Nauta JJ, Popp-Snijders C, Mulder C, Donker AJ. Dose-response effects of fish-oil supplementation in healthy volunteers. Am J Clin Nutr. 1990;52:120-127.
26. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest. 2001;107:1339-1345.
27. Chensue SW, Kunkel SL. Arachidonic acid metabolism and macrophage activation. Clin Lab Med. 1983;3:677-694.
28. Bernard AC, Mistry SK, Morris SM Jr, et al. Alterations in arginine metabolic enzymes in trauma. Shock. 2001;15:215-219.
29. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 1999;189:1363-1372.
30. Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol. 2001;166:5398-5406.
31. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 2003;24:302-306.
32. Bronte V, Serafini P, Apolloni E, Zanovello P. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother. 2001;24:431-446.
33. Rodriguez PC, Zea AH, DeSalvo J, et al. L-Arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003;171:1232-1239.
34. Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem. 2002;277:21123-21129.
35. Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003;6:223-228.